Clinical Trial of Autologous CD19 CAR-T Cells (CNCT19) Therapy for Advanced Hepatocellular Carcinoma

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 7, 2025

Primary Completion Date

July 30, 2026

Study Completion Date

August 31, 2026

Conditions

Advanced Hepatocellular Carcinoma

Interventions

BIOLOGICAL

anti-CD19 CAR-T

All subjects were intravenous administrated with CNCT19 CAR-T.

Trial Locations (1)

First Affiliated Hospital, Medical College of Zhejiang University, Hangzhou